On 23rd June 2020, the Extraordinary General Meeting of shareholders of Helix Immuno-Oncology S.A. (“Company”) adopted a resol...
On 4th June 2022, the Extraordinary General Meeting of shareholders of Helix Immuno-Oncology S.A. adopted resolutions concerning c...
On 5th February 2020, HELIX IMMUNO-ONCOLOGY S.A. submitted the following documents related to the financial year lasting from 1st...